R. Pelka‐Fleischer

775 total citations
27 papers, 653 citations indexed

About

R. Pelka‐Fleischer is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, R. Pelka‐Fleischer has authored 27 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in R. Pelka‐Fleischer's work include Drug Transport and Resistance Mechanisms (8 papers), Acute Myeloid Leukemia Research (7 papers) and Retinoids in leukemia and cellular processes (4 papers). R. Pelka‐Fleischer is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Acute Myeloid Leukemia Research (7 papers) and Retinoids in leukemia and cellular processes (4 papers). R. Pelka‐Fleischer collaborates with scholars based in Germany, Austria and United States. R. Pelka‐Fleischer's co-authors include W. Wilmanns, Helga Schmetzer, Karin Pfister, V. Nuessler, V. Nüßler, Max Hasmann, Oliver J. Stoetzer, Frank Gieseler, Tanja Kroell and H. Zwierzina and has published in prestigious journals such as The Journal of Immunology, Biochemical Pharmacology and European Journal of Cancer.

In The Last Decade

R. Pelka‐Fleischer

27 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Pelka‐Fleischer Germany 15 279 277 206 205 62 27 653
Marina Lanciotti Italy 17 129 0.5× 267 1.0× 160 0.8× 204 1.0× 84 1.4× 51 733
Jenny Ho Canada 10 190 0.7× 274 1.0× 134 0.7× 221 1.1× 24 0.4× 25 584
GJ Schuurhuis Netherlands 14 375 1.3× 293 1.1× 240 1.2× 82 0.4× 60 1.0× 18 701
Karsten Stahnke Germany 15 150 0.5× 327 1.2× 197 1.0× 96 0.5× 191 3.1× 23 635
DL Urdal United States 13 159 0.6× 304 1.1× 271 1.3× 412 2.0× 26 0.4× 18 822
Subrata Banerjee India 13 159 0.6× 269 1.0× 92 0.4× 121 0.6× 30 0.5× 31 538
Bismarck B. Lozzio United States 10 126 0.5× 221 0.8× 107 0.5× 271 1.3× 48 0.8× 20 636
Carole Ferraro France 5 83 0.3× 160 0.6× 106 0.5× 157 0.8× 72 1.2× 5 510
Shwu‐Luan Lee United States 6 118 0.4× 353 1.3× 219 1.1× 79 0.4× 40 0.6× 7 655
Terry J. Gaymes United Kingdom 13 265 0.9× 585 2.1× 280 1.4× 80 0.4× 80 1.3× 24 800

Countries citing papers authored by R. Pelka‐Fleischer

Since Specialization
Citations

This map shows the geographic impact of R. Pelka‐Fleischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pelka‐Fleischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pelka‐Fleischer more than expected).

Fields of papers citing papers by R. Pelka‐Fleischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Pelka‐Fleischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pelka‐Fleischer. The network helps show where R. Pelka‐Fleischer may publish in the future.

Co-authorship network of co-authors of R. Pelka‐Fleischer

This figure shows the co-authorship network connecting the top 25 collaborators of R. Pelka‐Fleischer. A scholar is included among the top collaborators of R. Pelka‐Fleischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pelka‐Fleischer. R. Pelka‐Fleischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pelka‐Fleischer, R., et al.. (2006). Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.. PubMed. 11(8). 313–21. 52 indexed citations
2.
Zitzelsberger, Horst, Tanja Kroell, R. Pelka‐Fleischer, et al.. (2005). Leukemia‐Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum‐Free Culture Conditions. Scandinavian Journal of Immunology. 62(1). 86–98. 24 indexed citations
3.
Pelka‐Fleischer, R., et al.. (2005). High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. American Journal of Hematology. 79(1). 26–35. 30 indexed citations
4.
Zitzelsberger, Horst, Tanja Kroell, R. Pelka‐Fleischer, et al.. (2005). Leukaemia‐Derived Dendritic Cells Can Be Generated From Blood or Bone Marrow Cells From Patients With Myelodysplasia: A Methodological Approach Under Serum‐Free Culture Conditions. Scandinavian Journal of Immunology. 62(1). 75–85. 25 indexed citations
5.
Pelka‐Fleischer, R., et al.. (2004). Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. European Journal Of Haematology. 72(2). 89–106. 60 indexed citations
6.
Pelka‐Fleischer, R., et al.. (2004). High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Annals of Hematology. 84(5). 287–297. 58 indexed citations
7.
Pelka‐Fleischer, R., et al.. (2003). Low l‐selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. European Journal Of Haematology. 71(5). 366–376. 10 indexed citations
8.
Stoetzer, Oliver J., et al.. (2002). Modulation of apoptosis by mitochondrial uncouplers: apoptosis-delaying features despite intrinsic cytotoxicity. Biochemical Pharmacology. 63(3). 471–483. 21 indexed citations
9.
Salih, Helmut R., Gary C. Starling, R. Pelka‐Fleischer, et al.. (2002). Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo‐1) and Fas Ligand (CD178) expression. British Journal of Haematology. 117(1). 76–85. 10 indexed citations
10.
Hasmann, Max, et al.. (2002). Cytoprotective features of selenazofurin in hematopoietic cells. International Journal of Clinical Pharmacology and Therapeutics. 40(8). 368–375. 3 indexed citations
11.
Salih, Helmut R., Helga Schmetzer, Christine Burke, et al.. (2001). Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies. The Journal of Immunology. 167(7). 4059–4066. 52 indexed citations
12.
Pelka‐Fleischer, R., et al.. (1999). Drug-induced apoptosis in chronic lymphocytic leukemia. Leukemia. 13(11). 1873–1880. 33 indexed citations
13.
Nuessler, V., et al.. (1999). Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Leukemia. 13(11). 1864–1872. 42 indexed citations
14.
Nuessler, V., R. Pelka‐Fleischer, F. del Valle, et al.. (1997). Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. Annals of Hematology. 75(1-2). 17–26. 15 indexed citations
15.
Nüßler, V., Frank Gieseler, H. Zwierzina, et al.. (1997). Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression. Annals of Hematology. 74(2). 57–64. 9 indexed citations
16.
Pelka‐Fleischer, R., H. Zwierzina, Frank Gieseler, et al.. (1996). P-glycoprotein expression in patients with acute leukemia-clinical relevance.. PubMed. 10 Suppl 3. S23–S31. 38 indexed citations
17.
Nüßler, V., R. Pelka‐Fleischer, H. Zwierzina, et al.. (1994). Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal. Annals of Hematology. 69(1). S25–S29. 17 indexed citations
18.
Possinger, Kurt, et al.. (1993). Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 45(4). 315–319. 29 indexed citations
19.
Nüßler, V., H. Sauer, R. Pelka‐Fleischer, D. Hölzel, & W. Wilmanns. (1990). Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia. European Journal Of Haematology. 45(1). 19–25. 8 indexed citations
20.
Pelka‐Fleischer, R., et al.. (1987). Relation between cell cycle stage and the activity of DNA-synthesizing enzymes in cultured human lymphoblasts: investigations on cell fractions enriched according to cell cycle stages by way of centrifugal elutriation.. PubMed. 1(3). 182–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by Jenny Ho Breakdown of academic impact, for papers by GJ Schuurhuis Breakdown of academic impact, for papers by Karsten Stahnke Breakdown of academic impact, for papers by DL Urdal Breakdown of academic impact, for papers by Subrata Banerjee Breakdown of academic impact, for papers by Bismarck B. Lozzio Breakdown of academic impact, for papers by Carole Ferraro Breakdown of academic impact, for papers by Shwu‐Luan Lee Breakdown of academic impact, for papers by Terry J. Gaymes
Rankless by CCL
2026